These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3806733)

  • 1. Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).
    Tennant FS; Rawson RA; Pumphrey E; Seecof R
    J Subst Abuse Treat; 1986; 3(3):195-202. PubMed ID: 3806733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal.
    Mendelson JH; Ellingboe J; Judson BA; Goldstein A
    Clin Pharmacol Ther; 1984 Apr; 35(4):545-7. PubMed ID: 6705455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of methadyl acetate (LAAM) as compared with methadone in a treatment program for heroin addicts.
    Trueblood B; Judson BA; Goldstein A
    Drug Alcohol Depend; 1978 Mar; 3(2):125-32. PubMed ID: 631012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of LAAM and methadone utilization in an opiate agonist treatment program.
    Valdivia JF; Khattak S
    Mt Sinai J Med; 2000; 67(5-6):398-403. PubMed ID: 11064490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
    Newcombe DA; Bochner F; White JM; Somogyi AA
    Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levo-Alpha Acetyl Methadol (LAAM). Its advantages and drawbacks.
    Finn P; Wilcock K
    J Subst Abuse Treat; 1997; 14(6):559-64. PubMed ID: 9437627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of thrice weekly LAAM and daily methadone in employed heroin addicts.
    Freedman RR; Czertko G
    Drug Alcohol Depend; 1981 Nov; 8(3):215-22. PubMed ID: 7327086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction.
    Marcovici M; O'Brien CP; McLellan AT; Kacian J
    Am J Psychiatry; 1981 Feb; 138(2):234-6. PubMed ID: 7457647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
    Longshore D; Annon J; Anglin MD; Rawson RA
    Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of methadone and 1-alpha-acetylmethadol.
    Karp-Gelernter E; Wurmser L; Savage C
    Am J Psychiatry; 1976 Aug; 133(8):955-7. PubMed ID: 942010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine.
    Ling W; Rawson RA; Compton MA
    J Psychoactive Drugs; 1994; 26(2):119-28. PubMed ID: 7931856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. l-Alpha-acetylmethadol (LAAM): prognostic considerations.
    Resnick RB; Orlin L; Geyer G; Schuyten-Resnick E; Kestenbaum RS; Freedman AM
    Am J Psychiatry; 1976 Jul; 133(7):814-9. PubMed ID: 937573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials.
    Glanz M; Klawansky S; McAullife W; Chalmers T
    Am J Addict; 1997; 6(4):339-49. PubMed ID: 9398932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilization.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1979 Nov; 4(6):461-6. PubMed ID: 533680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levo-alpha-acetylmethadol (LAAM): clinical, research, and policy issues of a new pharmacotherapy for opioid addiction.
    Prendergast ML; Grella C; Perry SM; Anglin MD
    J Psychoactive Drugs; 1995; 27(3):239-47. PubMed ID: 8594167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical status of methadyl acetate (LAAM).
    Blaine JD; Renault PR; Thomas DB; Whysner JA
    Ann N Y Acad Sci; 1981; 362():101-15. PubMed ID: 7020527
    [No Abstract]   [Full Text] [Related]  

  • 19. Early clinical studies of levo-alpha acetylmethadol (LAAM): an opiate for use in the medical treatment of chronic heroin dependence.
    Blaine JD
    NIDA Res Monogr; 1978; (19):249-59. PubMed ID: 106289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog.
    Vaupel DB; Jasinski DR
    J Pharmacol Exp Ther; 1997 Nov; 283(2):833-42. PubMed ID: 9353405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.